137 related articles for article (PubMed ID: 22179556)
1. Allogeneic cellular and autologous stem cell therapy for sickle cell disease: 'whom, when and how'.
Freed J; Talano J; Small T; Ricci A; Cairo MS
Bone Marrow Transplant; 2012 Dec; 47(12):1489-98. PubMed ID: 22179556
[TBL] [Abstract][Full Text] [Related]
2. Hematopoietic stem cell transplantation for sickle cell disease: state of the science.
Talano JA; Cairo MS
Eur J Haematol; 2015 May; 94(5):391-9. PubMed ID: 25200500
[TBL] [Abstract][Full Text] [Related]
3. Smoothing the crescent curve: sickle cell disease.
Talano JA; Cairo MS
Hematology Am Soc Hematol Educ Program; 2014 Dec; 2014(1):468-74. PubMed ID: 25696896
[TBL] [Abstract][Full Text] [Related]
4. Hematopoietic stem cell transplantation and cellular therapy in sickle cell disease: where are we now?
Tanhehco YC; Bhatia M
Curr Opin Hematol; 2019 Nov; 26(6):448-452. PubMed ID: 31483336
[TBL] [Abstract][Full Text] [Related]
5. Will developments in allogeneic transplantation influence treatment of adult patients with sickle cell disease?
Chakrabarti S; Bareford D
Biol Blood Marrow Transplant; 2004 Jan; 10(1):23-31. PubMed ID: 14752776
[TBL] [Abstract][Full Text] [Related]
6. Allogeneic cellular gene therapy for hemoglobinopathies.
Gaziev J; Lucarelli G
Hematol Oncol Clin North Am; 2010 Dec; 24(6):1145-63. PubMed ID: 21075285
[TBL] [Abstract][Full Text] [Related]
7. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
Petersen SL
Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
[TBL] [Abstract][Full Text] [Related]
8. Allogeneic hematopoietic stem cell transplantation in children with sickle cell disease.
Locatelli F; Pagliara D
Pediatr Blood Cancer; 2012 Aug; 59(2):372-6. PubMed ID: 22544533
[TBL] [Abstract][Full Text] [Related]
9. Hematopoietic stem cell graft manipulation as a mechanism of immunotherapy.
Talmadge JE
Int Immunopharmacol; 2003 Aug; 3(8):1121-43. PubMed ID: 12860168
[TBL] [Abstract][Full Text] [Related]
10. Expanded indications for allogeneic stem cell transplantation in patients with myeloid malignancies.
Liu H; Stock W; Bishop MR
Curr Opin Hematol; 2013 Mar; 20(2):115-22. PubMed ID: 23385613
[TBL] [Abstract][Full Text] [Related]
11. Allogeneic hematopoietic stem cell transplantation for children with severe aplastic anemia.
Hutspardol S; Sirachainan N; Anurathapan U; Pakakasama S; Songdej D; Chuansumrit A; Sirireung S; Panthangkool W; Hongeng S
J Med Assoc Thai; 2013 Jan; 96 Suppl 1():S18-24. PubMed ID: 23724451
[TBL] [Abstract][Full Text] [Related]
12. Advances in allogeneic stem cell transplantation for hemoglobinopathies.
Al Jefri AH
Hemoglobin; 2011; 35(5-6):469-75. PubMed ID: 21967642
[TBL] [Abstract][Full Text] [Related]
13. Fludarabine-based conditioning for allogeneic transplantation in adults with sickle cell disease.
van Besien K; Bartholomew A; Stock W; Peace D; Devine S; Sher D; Sosman J; Chen YH; Koshy M; Hoffman R
Bone Marrow Transplant; 2000 Aug; 26(4):445-9. PubMed ID: 10982293
[TBL] [Abstract][Full Text] [Related]
14. Allogeneic stem cell transplantation in multiple myeloma relapsed after autograft: a multicenter retrospective study based on donor availability.
Patriarca F; Einsele H; Spina F; Bruno B; Isola M; Nozzoli C; Nozza A; Sperotto A; Morabito F; Stuhler G; Festuccia M; Bosi A; Fanin R; Corradini P
Biol Blood Marrow Transplant; 2012 Apr; 18(4):617-26. PubMed ID: 21820394
[TBL] [Abstract][Full Text] [Related]
15. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed hematologic malignancy following autologous stem cell transplantation.
Dey BR; McAfee S; Sackstein R; Colby C; Saidman S; Weymouth D; Poliquin C; Vanderklish J; Sachs DH; Sykes M; Spitzer TR
Biol Blood Marrow Transplant; 2001; 7(11):604-12. PubMed ID: 11760148
[TBL] [Abstract][Full Text] [Related]
16. Allogeneic stem cell transplantation after a fludarabine/busulfan-based reduced-intensity conditioning in patients with myelodysplastic syndrome or secondary acute myeloid leukemia.
Kröger N; Bornhäuser M; Ehninger G; Schwerdtfeger R; Biersack H; Sayer HG; Wandt H; Schäfer-Eckardt K; Beyer J; Kiehl M; Zander AR;
Ann Hematol; 2003 Jun; 82(6):336-42. PubMed ID: 12728337
[TBL] [Abstract][Full Text] [Related]
17. Successful allogeneic stem cell transplantation with nonmyeloablative conditioning in patients with relapsed Hodgkin's disease following autologous stem cell transplantation.
Ruiz-Argüelles GJ; López-Martínez B; López-Ariza B
Arch Med Res; 2003; 34(3):242-5. PubMed ID: 14567405
[TBL] [Abstract][Full Text] [Related]
18. Allogeneic cellular gene therapy in hemoglobinopathies--evaluation of hematopoietic SCT in sickle cell anemia.
Lucarelli G; Gaziev J; Isgrò A; Sodani P; Paciaroni K; Alfieri C; De Angelis G; Marziali M; Simone MD; Gallucci C; Roveda A; Saltarelli F; Torelli F; Andreani M
Bone Marrow Transplant; 2012 Feb; 47(2):227-30. PubMed ID: 21499319
[TBL] [Abstract][Full Text] [Related]
19. [Immune reconstitution after allogeneic stem cell transplantation using nonmyeloablative or reduced-intensity conditioning regimen].
Nakai K
Nihon Rinsho; 2003 Sep; 61(9):1542-8. PubMed ID: 14515721
[TBL] [Abstract][Full Text] [Related]
20. Curative treatment for severe sickle cell disease: allogeneic transplantation.
Oshrine B; Talano JA
Clin Adv Hematol Oncol; 2015 Apr; 13(4):249-56. PubMed ID: 26352583
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]